Pyridomycin
Pyridomycin (Erizomycin) is a selective and low cytotoxic inhibitor of Mycobacterium tuberculosis that effectively targets InhA. Pyrdomycin is also an antibiotic that can be obtained from metabolites of Dactylosporangium fulvum. Pyrdomycin can be used in the study of bacterial infections such as tuberculosis[1][2].
Product Specifications
CAS Number
18791-21-4
Product Name Alternative
Erizomycin; NSC 246134
UNSPSC
12352005
Target
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/pyridomycin.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=NC=CC=C1O)N[C@H](C(N[C@@H](CC2=CC=CN=C2)[C@@H](O)[C@H]3C)=O)[C@@H](C)OC(/C(OC3=O)=C(C)/CC)=O
Molecular Formula
C27H32N4O8
Molecular Weight
540.56
References & Citations
[1]Hartkoorn RC, et al. Towards a new tuberculosis drug: pyridomycin - nature's isoniazid. EMBO Mol Med. 2012 Oct;4 (10) :1032-42.|[2]Hartkoorn RC, et al. Pyridomycin bridges the NADH- and substrate-binding pockets of the enoyl reductase InhA. Nat Chem Biol. 2014 Feb;10 (2) :96-8.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PA2104-Dylight594 100 µg
Anti-Caspase-14/CASP14 Antibody Picoband®, Dylight594 Conjugate
Sign In for Pricing
View Details 
MBS1118585 Inquire
Recombinant Sulfolobus islandicus Dihydroxy-acid dehydratase (ilvD), partial
Sign In for Pricing
View Details